Completed PHASE4 INTERVENTIONAL 2-arm NCT00161616

Study Evaluating InductOs in Diaphyseal Tibia Fractures

A Prospective, Randomized, Controlled, Stratified Study of InductOs in Subjects With Open Diaphyseal Tibia Fractures Treated With Reamed Locked Intramedullary Nail Fixation

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Conditions Tibial Fractures

Interventions InductOs

Updated 6 times since 2017 Last updated: Jul 31, 2009 Started: Sep 30, 2003 Primary completion: Jul 31, 2008 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Tibial Fractures and is currently completed. Wyeth is now a wholly owned subsidiary of Pfizer leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wyeth is now a wholly owned subsidiary of Pfizer

Data source: Wyeth is now a wholly owned subsidiary of Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alcalá, Spain , Bergen, Norway , Berlin, Germany , Bialystok, Poland , Bloemfontein, South Africa , Bristol, United Kingdom , Bucharest, Romania , Cape Town, South Africa , Centurion, South Africa , Créteil, France and 14 more locations